疏肝补肾法治疗乳腺增生病98例体会

被引：6

作者：

何清邻

机构：

[1] 甘肃省泾川县人民医院

来源：

甘肃中医 | 2002年 / 06期

关键词：

乳腺腺体增生/中医疗法; 疏肝补肾; 中药内服; 中药外敷;

D O I：

暂无

中图分类号：

R271.44 [乳病];

学科分类号：

100509 ;

摘要：

引用

页码：60 / 61

页数：2

共 5 条

[1]

Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance[J] . Hariharan Easwaran,Hsing-Chen Tsai,Stephen B. Baylin. &nbspMolecular Cell . 2014 (5)

[2]

Antitumor activity of satraplatin in cisplatin-resistant oral squamous cell carcinoma cells. Yamano Yukio,Shiiba Masashi,Negoro Kenji,Nakatani Ken,Kasamatsu Atsushi,Yamatoji Masanobu,Sakuma Kentaro,Ogoshi Kenji,Iyoda Manabu,Shinozuka Keiji,Yokoe Hidetaka,Wada Takeshi,Fujita Shigeyuki,Iwasawa Shunichiro,Takiguchi Yuichi,Tanzawa Hide. Head and Neck . 2010

[3]

Multidrug resistance in oral squamous cell carcinoma: The role of vacuolar ATPases[J] . Mario Pérez-Sayáns,José Manuel Somoza-Martín,Francisco Barros-Angueira,Pilar Gayoso Diz,José Manuel Gándara Rey,Abel García-García. &nbspCancer Letters . 2010 (2)

[4] Chemotherapeutic inhibitors in the treatment of prostate cancer [J].

Deshmukh, Rahul R. ;

Schmitt, Sara M. ;

Hwang, Clara ;

Dou, Qing Ping .

EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (01) :11-22

[5]

Microarray-Assisted Pathway Analysis Identifies MT1X & NFκB as Mediators of TCRP1-Associated Resistance to Cisplatin in Oral Squamous Cell Carcinoma. Peng Bo,Gu Yixue,Xiong Yan,Zheng Guopei,He Zhimin. PloS one . 2012

← 1 →